These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 24740645)

  • 1. FRETS-VWF73 rather than CBA assay reflects ADAMTS13 proteolytic activity in acquired thrombotic thrombocytopenic purpura patients.
    Mancini I; Valsecchi C; Lotta LA; Deforche L; Pontiggia S; Bajetta M; Palla R; Vanhoorelbeke K; Peyvandi F
    Thromb Haemost; 2014 Aug; 112(2):297-303. PubMed ID: 24740645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a chromogenic commercial assay using VWF-73 peptide for ADAMTS13 activity measurement.
    Joly B; Stepanian A; Hajage D; Thouzeau S; Capdenat S; Coppo P; Veyradier A
    Thromb Res; 2014 Nov; 134(5):1074-80. PubMed ID: 25262108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay.
    Kokame K; Nobe Y; Kokubo Y; Okayama A; Miyata T
    Br J Haematol; 2005 Apr; 129(1):93-100. PubMed ID: 15801961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development and application of a new ADAMTS13 assay for TTP diagnosis].
    Kokame K; Miyata T
    Rinsho Byori; 2005 Jul; 53(7):639-45. PubMed ID: 16104533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage site.
    Raife TJ; Cao W; Atkinson BS; Bedell B; Montgomery RR; Lentz SR; Johnson GF; Zheng XL
    Blood; 2009 Aug; 114(8):1666-74. PubMed ID: 19541819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cattle-FRETS71, a novel fluorogenic substrate with broad applicability for characterizing ADAMTS13 properties and function.
    Barton JC; Anderson C; Miranda FZ; Kelley R; Kremer Hovinga JA; Terrell D; Vesely SK; George JN; Muia J
    J Thromb Haemost; 2023 Dec; 21(12):3393-3401. PubMed ID: 37633642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An optimized fluorogenic ADAMTS13 assay with increased sensitivity for the investigation of patients with thrombotic thrombocytopenic purpura.
    Muia J; Gao W; Haberichter SL; Dolatshahi L; Zhu J; Westfield LA; Covill SC; Friedman KD; Sadler JE
    J Thromb Haemost; 2013 Aug; 11(8):1511-8. PubMed ID: 23773695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel flow-based assay reveals discrepancies in ADAMTS-13 inhibitor assessment as compared with a conventional clinical static assay.
    Grillberger R; Gruber B; Skalicky S; Schrenk G; Knöbl P; Plaimauer B; Turecek PL; Scheiflinger F; Rottensteiner H
    J Thromb Haemost; 2014 Sep; 12(9):1523-32. PubMed ID: 25040659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of von Willebrand factor pro-peptide and ADAMTS13 in diagnosis of thrombotic thrombocytopenic purpura].
    Ji J; Liu T; Meng WT; Lu ZP
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 42(6):807-10. PubMed ID: 22332547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
    Gerritsen HE; Turecek PL; Schwarz HP; Lämmle B; Furlan M
    Thromb Haemost; 1999 Nov; 82(5):1386-9. PubMed ID: 10595623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a New, Rapid, Fully Automated Assay for the Measurement of ADAMTS13 Activity.
    Valsecchi C; Mirabet M; Mancini I; Biganzoli M; Schiavone L; Faraudo S; Mane-Padros D; Giles D; Serra-Domenech J; Blanch S; Trisolini SM; Facchini L; Rinaldi E; Peyvandi F
    Thromb Haemost; 2019 Nov; 119(11):1767-1772. PubMed ID: 31587247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FRETS-VWF73: a rapid and predictive tool for thrombotic thrombocytopenic purpura.
    Groot E; Hulstein JJ; Rison CN; de Groot PG; Fijnheer R
    J Thromb Haemost; 2006 Mar; 4(3):698-9. PubMed ID: 16460463
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of FRETS-VWF73 to full-length VWF as a substrate for ADAMTS13 activity measurement in human plasma samples.
    Mahdian R; Rayes J; Girma JP; Houllier A; Obert B; Meyer D; Veyradier A
    Thromb Haemost; 2006 Jun; 95(6):1049-51. PubMed ID: 16732393
    [No Abstract]   [Full Text] [Related]  

  • 14. [Expression of vWF73 and VWF114 fragments of von Willebrand factor A2 domain and their utilization in detecting ADAMTS13 activity].
    Zhang JY; Ma ZN; Dong NZ; Hu LP; Su J; Wang ZY; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2011 May; 32(5):337-41. PubMed ID: 21729605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolytic inactivation of ADAMTS13 by plasmin in human plasma: risk of thrombotic thrombocytopenic purpura.
    Shin Y; Miyake H; Togashi K; Hiratsuka R; Endou-Ohnishi K; Imamura Y
    J Biochem; 2018 May; 163(5):381-389. PubMed ID: 29228282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of four ADAMTS13 mutations responsible for congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome).
    Hommais A; Rayes J; Houllier A; Obert B; Legendre P; Veyradier A; Girma JP; Ribba AS
    Thromb Haemost; 2007 Sep; 98(3):593-9. PubMed ID: 17849048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular biology of ADAMTS13 and diagnostic utility of ADAMTS13 proteolytic activity and inhibitor assays.
    Shelat SG; Ai J; Zheng XL
    Semin Thromb Hemost; 2005 Dec; 31(6):659-72. PubMed ID: 16388417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
    Kato S; Fujimura Y
    Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of the FRETS-vWF73 assay in the patients with thrombotic thrombocytopenic purpura (TTP)].
    Hu LP; Su J; Han Y
    Zhonghua Xue Ye Xue Za Zhi; 2012 Sep; 33(9):761-2. PubMed ID: 23336235
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.